LATEST

FDA: Risk of blindness from compounded eye drugFDA warns that this compounded eye drug could lead to a disease that causes blindness.
First Zika test for blood donations wins nod from FDA
Novel device helps diabetics avoid stress linked to glucose testingFDA approved the first continuous glucose monitoring system that allows for diabetes treatment decisions without requiring a fingerstick.
New drug offers hope to advanced breast cancer patientsFDA approved a new treatment for certain breast cancer patients who are not responding to treatment.
Cholesterol drug misbranded, company pleads guilty
Cholesterol drug misbranded, company pleads guiltyPharma maker pleads guilty that one of its major drugs was misbranded in a federal court case brought by FDA and the US Department of Justice.
FDA warns Pfizer’s Meridian over EpiPen flawsFDA warned about an injunction or seizure if Meridian Medical Technologies, a division of Pfizer, does not correct its problems with the EpiPen (epinephrine auto-injector).
FDA warns about deaths in cancer drug trials
FDA warns about deaths in cancer drug trialsAn increased risk of deaths for patients in clinical trials receiving this cancer drug and two other drugs led FDA to stop the clinical trials.
Blockbuster diabetes drug earns heart indication
Blockbuster diabetes drug earns heart indicationA top-selling diabetes drug has gained a cardiovascular indication from FDA.
Will new biosimilars hurt blockbuster autoimmune drug?
Will new biosimilars hurt blockbuster autoimmune drug?New biosimilars may harm the sales of this autoimmune blockbuster.
FDA okays targeted leukemia treatmentFDA approved a targeted new drug to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia.

Poll

View Results